Clinical Trials in Tennessee

Showing 20101-20120 of 20,239 trials

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

NCT00087542

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

HallucinationsPsychosesParkinson's Disease

ACADIA Pharmaceuticals Inc.60 participantsStarted Mar 2004

Fountain Valley, California, United States • Sunnyvale, California, United States • Danbury, Connecticut, United States +10 more locations

COMPLETEDPhase 229 miles

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

NCT00045864

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.

Lymphoma, Non-Hodgkin

Chiron Corporation

Tucson, Arizona, United States • Newport Beach, California, United States • Sacramento, California, United States +30 more locations

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Find Trials by Condition in Tennessee

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Xcellerated T CellsTM in Patients With Multiple Myeloma

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain

A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Study of NS-9 in Patients With Liver Metastases